Aug. 8, 2012 — The Berlin Heart Group said the U.S. Food and Drug Administration (FDA) has granted approval for its post approval study, a condition of the humanitarian device exemption (HDE) approval that Berlin Heart received for the Excor Pediatric Ventricular Assist Device (VAD) in December 2011.
Aug. 8, 2012 — iHeart Centers acquired the Heart IT WebPAX system for facilitating the management of medical images. The zero-footprint medical image workstation provides Web-based medical image management technology and services to healthcare systems, large hospitals and private clinics.
August 3, 2012 — In a bid to help control healthcare costs, on Oct 1, 2012, the Centers for Medicare and Medicaid Services (CMS) will stop paying hospitals for treating potentially avoidable surgical site infections following cardiac implantable electronic device (CIED) procedures. These include pacemaker and defibrillator implants.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
August 3, 2012 — St. Jude Medical recently announced initial findings from the Riata lead evaluation study. The study’s phase I results found that externalized conductors occurred in 9.3 percent of the smaller-diameter Riata ST 7 French leads in the study, and in 24 percent of the larger-diameter Riata 8 French leads.
August 3, 2012 — GE Healthcare announced it has already received six orders for its Discovery IGS 730 system since receiving U.S. Food and Drug Administration (FDA) clearance in February 2012.
August 3, 2012 — FluoroPharma Medical Inc. announced that they have received high-quality images in an investigator-sponsored clinical trial in China where patients with coronary artery disease (CAD) were given BFPET, its imaging agent for measuring cardiovascular blood flow.
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
August 2, 2012 — According to new research published in the August issue of the Journal of Nuclear Medicine, single photon emission computed tomography/computed tomography (SPECT/CT) with 99mTc-hexamethylpropleneamine oxime-labeled white blood cells (99mTc-HMPAO-WBC) can improve the diagnosis of infectious endocarditis in hard-to-diagnose cases.
August 2, 2012 — Results of the ROMICAT II trial indicates coronary computed tomography (CT) angiography (CCTA) as a safe and time-efficient noninvasive modality to evaluate patients with chest pain in the emergency department (ED) when compared to the current standard approach.
August 2, 2012 — The Heart Rhythm Society (HRS) and the American College of Cardiology Foundation (ACCF) has released the HRS/ACCF Expert Consensus Statement on Pacemaker Device and Mode Selection, the first of its kind to specifically address pacemaker device and mode selection.
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
Interventional procedures are growing rapidly and becoming more specialized in diverse areas of care. In the next decade, the number of people living in the United States who have heart conditions is expected to continue to increase, as is the elderly segment of the population and the number of people with chronic disorders such as cardiovascular disease cancer, diabetes and obesity.[1] Driven by these trends and enabled by breakthrough technology allowing new, less invasive approaches to therapy, hospitals are looking at the interventional suite as a strategic area of investment.
July 31, 2012 — Bracco Diagnostics Inc., the U.S.-based company of the Bracco Group, announced that the U.S. Food and Drug Administration (FDA) has approved the use of MultiHance (gadobenate dimeglumine) injection, 529 mg/mL, in magnetic resonance angiography (MRA) to evaluate adults with known or suspected renal or aorto-ilio-femoral occlusive vascular disease.
July 31, 2012 — Boston Scientific Corp. has received CE mark approval for use of its Ingenio and Advantio pacemakers in patients in need of a magnetic resonance image (MRI).
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
In the coming years, the continued growth and aging of our population will both increase the demand for treatment with implantable cardiac rhythm devices and stretch our ability to pay for care. Toward solving this, we must continue to improve clinical quality not just to provide a better future for patients, but to control costs so that we are able to meet the increased demand.
July 31, 2012 – Diagnostic and Interventional Cardiology (DAIC) has applied for business publication membership in BPA Worldwide, which will track DAIC's circulation. The tracking includes business/distribution, demographics and geographic coverage. The magazine will have 12 months to complete its initial circulation audit.
July 31, 2012 — Siemens Healthcare announced that the Magnetom Spectra 3.0T magnetic resonance imaging (MRI) system has received clearance from the U.S. Food and Drug Administration (FDA).